Guardat en:
| Autor principal: | |
|---|---|
| Format: | Recurso digital |
| Idioma: | |
| Publicat: |
Zenodo
2025
|
| Matèries: | |
| Accés en línia: | https://doi.org/10.5281/zenodo.18072829 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| _version_ | 1866901211591999488 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The literature indicates that the resumption of aspirin post-hematuria from pyelonephritis requires a careful evaluation of the infection's resolution and the risks versus benefits of aspirin therapy. Consultation with healthcare providers is essential for individualized decision-making. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18072829 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | How soon can daily aspirin be resumed after an episode of hematuria due to pyelonephritis? Tripdatabase soon daily aspirin resumed after episode hematuria due pyelonephritis The literature indicates that the resumption of aspirin post-hematuria from pyelonephritis requires a careful evaluation of the infection's resolution and the risks versus benefits of aspirin therapy. Consultation with healthcare providers is essential for individualized decision-making. |
| title | How soon can daily aspirin be resumed after an episode of hematuria due to pyelonephritis? |
| topic | soon daily aspirin resumed after episode hematuria due pyelonephritis |
| url | https://doi.org/10.5281/zenodo.18072829 |